Anti-IGF1R/CD221 Antibody (Cixutumumab)
Catalog No.
F1495
Anti-IGF1R/CD221 Antibody (Cixutumumab)
Featured Products
Cixutumumab (IMC-A12) is a high-affinity humanized anti-IGF-1R monoclonal antibody that inhibits ligand-dependent receptor activation and downstream signaling. Cixutumumab also mediates internalization and degradation of IGF-IR. Cixutumumab has broad-spectrum anti-tumor activity and can be used in the study of cancers such as lung cancer, malignancies, leukemia, non-small cell lung cancer, and prostate cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
150 kDa
Dry ice
947687-12-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
NSC-742460, NSC 742460
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P08069
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
IGF1R / CD221
Please avoid freeze-thaw cycles.